132 related articles for article (PubMed ID: 24882786)
1. Background parenchymal enhancement in breast MRIs of breast cancer patients: impact on tumor size estimation.
Baek JE; Kim SH; Lee AW
Eur J Radiol; 2014 Aug; 83(8):1356-62. PubMed ID: 24882786
[TBL] [Abstract][Full Text] [Related]
2. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
3. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
[TBL] [Abstract][Full Text] [Related]
4. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
5. Background enhancement of mammary glandular tissue on breast dynamic MRI: imaging features and effect on assessment of breast cancer extent.
Uematsu T; Kasami M; Watanabe J
Breast Cancer; 2012 Jul; 19(3):259-65. PubMed ID: 21618028
[TBL] [Abstract][Full Text] [Related]
6. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
[TBL] [Abstract][Full Text] [Related]
7. The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
Clin Breast Cancer; 2016 Dec; 16(6):e145-e152. PubMed ID: 27566960
[TBL] [Abstract][Full Text] [Related]
8. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
9. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
[TBL] [Abstract][Full Text] [Related]
10. Foci on breast magnetic resonance imaging in high-risk women: cancer or not?
Clauser P; Cassano E; De Nicolò A; Rotili A; Bonanni B; Bazzocchi M; Zuiani C
Radiol Med; 2016 Aug; 121(8):611-7. PubMed ID: 27169908
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.
Yamaguchi K; Schacht D; Newstead GM; Bradbury AR; Verp MS; Olopade OI; Abe H
AJR Am J Roentgenol; 2013 Nov; 201(5):1155-63. PubMed ID: 24147491
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
13. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
[TBL] [Abstract][Full Text] [Related]
14. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy.
Uematsu T; Kasami M
AJR Am J Roentgenol; 2012 May; 198(5):1223-30. PubMed ID: 22528918
[TBL] [Abstract][Full Text] [Related]
15. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.
van der Velden BH; Dmitriev I; Loo CE; Pijnappel RM; Gilhuijs KG
Radiology; 2015 Sep; 276(3):675-85. PubMed ID: 25811614
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
17. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
Giess CS; Yeh ED; Raza S; Birdwell RL
Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
[TBL] [Abstract][Full Text] [Related]
18. Undiagnosed breast cancer at MR imaging: analysis of causes.
Pages EB; Millet I; Hoa D; Doyon FC; Taourel P
Radiology; 2012 Jul; 264(1):40-50. PubMed ID: 22523324
[TBL] [Abstract][Full Text] [Related]
19. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
[TBL] [Abstract][Full Text] [Related]
20. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
Seely JM; Nguyen ET; Jaffey J
Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]